Page last updated: 2024-08-18

pyrazolanthrone and Bone Loss, Osteoclastic

pyrazolanthrone has been researched along with Bone Loss, Osteoclastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbas, S; Abu-Amer, Y; Dai, S; Hirayama, T; Yamanaka, Y1
Abu-Amer, Y; Clohisy, JC; Faccio, R; Yamanaka, Y1

Other Studies

2 other study(ies) available for pyrazolanthrone and Bone Loss, Osteoclastic

ArticleYear
Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation.
    Arthritis and rheumatism, 2005, Volume: 52, Issue:9

    Topics: Animals; Anthracenes; Arthritis, Experimental; Bone Marrow Cells; Bone Resorption; Carrier Proteins; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; JNK Mitogen-Activated Protein Kinases; Leg Bones; Macrophages; MAP Kinase Kinase 4; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Knockout; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Osteoclasts; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction; STAT6 Transcription Factor; Trans-Activators

2005
Map kinase c-JUN N-terminal kinase mediates PMMA induction of osteoclasts.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2006, Volume: 24, Issue:7

    Topics: Animals; Anthracenes; Arthroplasty, Replacement; Bone Resorption; DNA; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Male; Mesenchymal Stem Cells; Mice; Mice, Knockout; Osteoclasts; Phosphorylation; Polymethyl Methacrylate; Toll-Like Receptor 4; Transcription Factor AP-1

2006